DORM
Dorman Products, Inc.
NasdaqGSUSDEQUITY
Consumer Cyclical
DELAYED
Last price
132.12
▲ 0.75 (0.57%)
MARKET · —
Price
Open
132.97
Prev close
131.37
Day high
133.39
Day low
131.50
Volume
132.33K
Market cap
$3.92B
P/E (TTM)
18.30
52W range
98.45 – 166.89
Trailing performance
Returnvs SPY
1W
-3.13%
-1.8%
1M
-0.17%
-3.9%
3M
+11.31%
+8.2%
6M
+1.87%
-9.2%
YTD
+7.25%
-5.0%
1Y
-14.24%
-34.2%
3Y
+57.76%
-16.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$3.92B
Enterprise value$4.32B
Revenue (TTM)$2.16B
Gross profit$911.90M
EBITDA$420.60M
Net income$219.30M
EPS (TTM)$7.22
Free cash flow$143.99M
Total cash$131.98M
Total debt$528.25M
Book value / share$51.07
Shares outstanding29.68M
Float26.12M
Short % of float8.69%
Dividend yield—
Beta (5Y)0.99
Valuation & profitability ratios
Trailing P/E18.30
Forward P/E14.23
PEG ratio1.17
Price / sales—
Price / book2.59
EV / revenue2.00
EV / EBITDA10.26
Gross margin42.31%
Operating margin23.63%
Profit margin10.18%
Return on equity15.05%
Return on assets9.17%
Debt / equity34.87
Current ratio3.60
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $2.13B | $2.01B | $1.93B | $1.73B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $204.19M | $190.00M | $129.26M | $121.55M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $204.19M | $190.00M | $129.26M | $121.55M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.89 | 3.08 | +62.9% |
| Mar 2026 | 1.56 | 1.57 | +0.9% |
| Dec 2025 | 2.12 | 2.17 | +2.4% |
| Sep 2025 | 2.50 | 2.62 | +5.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.00 | 8 | $565.34M | +4.0% |
| Next quarter | 2.02 | 8 | $570.21M | +6.0% |
| Current year | 8.67 | 8 | $2.21B | +3.7% |
| Next year | 9.29 | 8 | $2.32B | +5.0% |
Analyst targets & ownership
Mean target$162.38
High target$170.00
Low target$154.00
Implied upside22.90%
Analyst count8
ConsensusSTRONG BUY
Strong buy / Buy2 / 5
Hold1
Sell / Strong sell0 / 0
Held by insiders12.85%
Held by institutions99.30%
Institutions holding450
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+84.55K
Net buying
Buy transactions
25
91.77K shares
Sell transactions
4
7.21K shares
Net transactions
+29
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
3.81M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | LONG DONNA M. Chief Technology Officer |
SELL | 734 | $99.24K | Direct |
| Aug 5, 26 | BOWEN GREGORY C. Officer |
SELL | 3.53K | $512.01K | Direct |
| Aug 5, 26 | BOWEN GREGORY C. Officer |
CONVERSION | 3.53K | $332.34K | Direct |
| Jun 1, 26 | BOWEN GREGORY C. Officer |
STOCK | 215 | $24.93K | Direct |
| Jun 1, 26 | THOMAS JAMES DARRELL Director |
STOCK | 1.34K | $164.92K | Direct |
| Jun 1, 26 | RILEY RICHARD T Director |
STOCK | 1.34K | $164.92K | Direct |
| Jun 1, 26 | STAKIAS MICHAEL G Director |
STOCK | 1.34K | $164.92K | Direct |
| Jun 1, 26 | BACHMANN LISA M Director |
STOCK | 1.34K | $164.92K | Direct |
| Jun 1, 26 | ROMANO KELLY A Director |
STOCK | 1.34K | $164.92K | Direct |
| Jun 1, 26 | BERMAN STEVEN L Director |
STOCK | 1.34K | $164.92K | Direct |
| Jun 1, 26 | GAVIN JOHN J Director |
STOCK | 1.34K | $164.92K | Direct |
| Mar 12, 26 | LONG DONNA M. Chief Technology Officer |
SELL | 947 | $97.61K | Direct |
| Mar 2, 26 | BRAUN JOSEPH P General Counsel |
STOCK | 4.31K | $499.89K | Direct |
| Mar 2, 26 | BOWEN GREGORY C. Officer |
STOCK | 646 | $74.89K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BERMAN STEVEN L |
Director | 885.80K | Stock Award(Grant) |
BRAUN JOSEPH P |
General Counsel | 21.27K | Stock Award(Grant) |
DARBY JEFFERY L. |
Officer | 18.42K | Stock Award(Grant) |
LEFF SCOTT |
Officer | 18.54K | Stock Award(Grant) |
LONG DONNA M. |
Chief Technology Officer | 19.34K | Sale |
LUFTIG ERIC |
Officer | 13.13K | Stock Award(Grant) |
OLSEN KEVIN M. |
Chief Executive Officer | 103.93K | Stock Award(Grant) |
RILEY RICHARD T |
Director | 30.31K | Stock Award(Grant) |
ROMANO KELLY A |
Director | 12.17K | Stock Award(Grant) |
STAKIAS MICHAEL G |
Director | 16.15K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
133.36
-0.93% from price
SMA 20
135.81
-2.72% from price
SMA 50
134.73
-1.94% from price
SMA 100
125.07
+5.63% from price
SMA 200
124.13
+6.43% from price
EMA 12
134.08
-1.46% from price
EMA 26
134.83
-2.01% from price
EMA 50
133.06
-0.70% from price
RSI (14)
46.5
Neutral
MACD (12,26,9)
-0.75
Hist -0.68
ATR (14)
5.84
4.42% of price
Realised vol 30D
59.2%
Annualised
Bollinger upper
145.27
20, 2σ
Bollinger lower
126.36
20, 2σ
50 / 200 cross
Golden
134.73 vs 124.13
Trend bias
Above 200
+6.43%
Risk profile
Beta vs SPY
0.80
Less volatile than market
Correlation to SPY
0.27
Largely independent
Realised vol 30D
59.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-39.6%
Peak to trough
Max drawdown 5Y
-49.3%
Peak to trough
ATR 14
5.84
4.42% of price
Beta (reported)
0.99
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
14.00
Put-heavy session
Put / call open interest
2.97
Positioning, not flow
Max pain
135.00
+2.2% from spot
ATM implied vol
51.9%
Nearest strike to spot
Skew (10% OTM)
-1.1%
Calls bid over puts
Call volume
3
Contracts, this expiry
Put volume
42
Contracts, this expiry
Heaviest call OI
140.00
10 contracts
Heaviest put OI
125.00
38 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Dorman Products (DORM) Q2 2026 Earnings Call Transcript
Motley Fool · 12d ago
The Bull Case For Dorman Products (DORM) Could Change Following Strong EPS Beat And Tighter 2026 Outlook
Simply Wall St. · 15d ago
What Makes Dorman Products (DORM) a New Buy Stock
Zacks · 16d ago
Dorman Products Inc (DORM) (Q2 2026) Earnings Call Highlights: Record Sales and EPS Fueled by ...
GuruFocus.com · 18d ago
Update: Dorman Products Shares Rise After Q2 Adjusted Earnings Beat, Full-Year EPS Guidance Boost
MT Newswires · 18d ago
Dorman Products Q2 Earnings Call Highlights
MarketBeat · 18d ago
Dorman Products, Inc. Q2 2026 Earnings Call Summary
Moby · 18d ago
Dorman Products (DORM) Q2 Earnings Top Estimates
Zacks · 19d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.